关于皮肤冠状动脉干预中的血小板功能和遗传检测的国际共识声明:2024年更新
Dominick J Angiolillo1, Mattia Galli2, Dimitrios Alexopoulos3
1Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA.
JACC. Cardiovascular interventions
|November 27, 2024
概括
在冠状动脉干预后,个性化抗血小板治疗至关重要. 血小板功能和基因检测可以指导P2Y12抑制剂的选择,以平衡出血和凝血风险.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床实践 临床实践
背景情况:
- 使用阿司匹林和P2Y12抑制剂的双抗血小板治疗 (DAPT) 是穿皮冠状动脉干预后的标准.
- DAPT增加了出血风险,需要个性化治疗策略.
- 在患者中平衡出血和缺血风险是具有挑战性的.
研究的目的:
- 提供专家建议,使用血小板功能和基因测试来个性化P2Y12抑制剂选择.
- 解决当前关于这些试验临床实施的指导方针中的差距.
主要方法:
- 对口服P2Y12抑制剂 (克洛皮多格雷尔,普拉苏格雷尔,蒂卡格雷勒) 药动力学概况的现有证据的审查.
- 对高残留血小板反应性和低血小板反应性数据的分析.
- 由一个由国际专家组成的小组制定共识.
主要成果:
- 高达三分之一的克洛皮多格勒使用者表现出高残留血小板反应性,增加了血栓形成的风险.
- 普拉苏格勒和提卡格勒尔与一些患者的血小板反应性低和出血风险增加有关.
- 血小板功能和基因检测可以指导P2Y12抑制剂的选择,但试验结果不统一.
结论:
- 专家的共识为根据个体患者的风险量身定制抗血小板治疗提供了指导.
- 血小板检测可以优化P2Y12抑制剂的选择,以改善皮肤冠状动脉干预后的结果.
- 需要进一步的研究和指导方针更新才能得到广泛的实施.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
469
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
469
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
01:22Formation of the Platelet Plug
4.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.5K